Cargando…
Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy: A protocol for systematic review and meta-analysis
BACKGROUND: Idiopathic membranous nephropathy (IMN) is one of the leading causes of nephrotic syndrome in adults. We performed a protocol for systematic review and meta-analysis to compare the efficacy and safety of cyclophosphamide (CTX) with calcineurin inhibitors (CNIs) in the treatment of IMN. M...
Autores principales: | Li, Kang, Yu, Yanqiu, Gao, Yuan, Gao, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878815/ https://www.ncbi.nlm.nih.gov/pubmed/35212292 http://dx.doi.org/10.1097/MD.0000000000028891 |
Ejemplares similares
-
Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021) -
Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021) -
The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)
por: Peng, Wei, et al.
Publicado: (2016) -
Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: A protocol of systematic review and meta-analysis of randomized controlled trials
por: Xue, Guozhong, et al.
Publicado: (2021) -
Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
por: Wang, Dan, et al.
Publicado: (2023)